Core Scientific Valuation
| CORZ Stock | USD 17.99 0.85 4.51% |
At this time, the firm appears to be undervalued. Core Scientific Common shows a prevailing Real Value of $21.05 per share. The current price of the firm is $17.99. Our model approximates the value of Core Scientific Common from analyzing the firm fundamentals such as Return On Asset of -0.0606, operating margin of (0.60) %, and Shares Outstanding of 310.06 M as well as examining its technical indicators and probability of bankruptcy.
Enterprise Value | Enterprise Value Ebitda 454.8804 | Price Sales 17.4802 | Forward PE 29.1545 | Enterprise Value Revenue 19.5982 |
Undervalued
Today
Please note that Core Scientific's price fluctuation is not too volatile at this time. Calculation of the real value of Core Scientific Common is based on 3 months time horizon. Increasing Core Scientific's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Core Scientific is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Core Stock. However, Core Scientific's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.99 | Real 21.05 | Target 26.91 | Hype 17.93 | Naive 16.67 |
The intrinsic value of Core Scientific's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Core Scientific's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Core Scientific Common helps investors to forecast how Core stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Core Scientific more accurately as focusing exclusively on Core Scientific's fundamentals will not take into account other important factors: Core Scientific Cash |
|
Core Scientific Total Value Analysis
Core Scientific Common is currently projected to have valuation of 6.55 B with market capitalization of 5.84 B, debt of 1.2 B, and cash on hands of 29.55 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Core Scientific fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.55 B | 5.84 B | 1.2 B | 29.55 M |
Core Scientific Investor Information
About 97.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 2.16. Core Scientific Common had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Core Scientific's historical financial statements, Core Scientific Common may be sliding down financialy. It has an above-average chance of going through some form of financial crunch next quarter.Core Scientific Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Core Scientific has an asset utilization ratio of 31.94 percent. This suggests that the Company is making $0.32 for each dollar of assets. An increasing asset utilization means that Core Scientific Common is more efficient with each dollar of assets it utilizes for everyday operations.Core Scientific Profitability Analysis
Based on the measurements of profitability obtained from Core Scientific's financial statements, Core Scientific Common may not be well positioned to generate adequate gross income at the present time. It has a very high chance of underperforming in March. Profitability indicators assess Core Scientific's ability to earn profits and add value for shareholders.Net Loss | First Reported 2010-12-31 | Previous Quarter -1.2 B | Current Value -1.1 B | Quarterly Volatility 687.9 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.17 | 0.21 |
|
|
For Core Scientific profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Core Scientific Common to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Core Scientific utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Core Scientific's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Core Scientific over time as well as its relative position and ranking within its peers.
Core Scientific Earnings per Share Projection vs Actual
The next projected EPS of Core Scientific is estimated to be 0.01 with future projections ranging from a low of -0.1 to a high of 0.12. Core Scientific's most recent 12-month trailing earnings per share (EPS TTM) is at -2.16. Please be aware that the consensus of earnings estimates for Core Scientific Common is based on EPS before non-recurring items and includes expenses related to employee stock options.Core Scientific Earnings Estimation Breakdown
The calculation of Core Scientific's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Core Scientific is estimated to be 0.01 with the future projection ranging from a low of -0.1 to a high of 0.12. Please be aware that this consensus of annual earnings estimates for Core Scientific Common is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.1 Lowest | Expected EPS | 0.12 Highest |
Core Scientific Earnings Projection Consensus
Suppose the current estimates of Core Scientific's value are higher than the current market price of the Core Scientific stock. In this case, investors may conclude that Core Scientific is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Core Scientific's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of March 2026 | Current EPS (TTM) | |
| 18 | 0.0% | 0.0 | 0.01 | -2.16 |
Core Scientific Ownership Allocation
The majority of Core Scientific Common outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Core Scientific Common to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Core Scientific. Please pay attention to any change in the institutional holdings of Core Scientific Common as this could imply that something significant has changed or is about to change at the company.Core Scientific Profitability Analysis
The company reported the previous year's revenue of 510.67 M. Net Loss for the year was (1.32 B) with profit before overhead, payroll, taxes, and interest of 34.13 M.About Core Scientific Valuation
Our relative valuation model uses a comparative analysis of Core Scientific. We calculate exposure to Core Scientific's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Core Scientific's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 139.2 M | 93.8 M | |
| Pretax Profit Margin | (2.96) | (2.81) | |
| Operating Profit Margin | (0.04) | (0.05) | |
| Net Loss | (2.96) | (2.81) | |
| Gross Profit Margin | 0.21 | 0.17 |
Core Scientific Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 255.8 M | |
| Quarterly Earnings Growth Y O Y | 0.612 | |
| Forward Price Earnings | 29.1545 |
Core Scientific Current Valuation Indicators
Valuation refers to the process of determining the present value of Core Scientific Common and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Core we look at many different elements of the entity such as Core's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Core Scientific, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Core Scientific's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Core Scientific's worth.Additional Tools for Core Stock Analysis
When running Core Scientific's price analysis, check to measure Core Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Scientific is operating at the current time. Most of Core Scientific's value examination focuses on studying past and present price action to predict the probability of Core Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Scientific's price. Additionally, you may evaluate how the addition of Core Scientific to your portfolios can decrease your overall portfolio volatility.